Literature DB >> 12211650

Immunoassay of anti-thyroid autoantibodies: high analytical variability in second generation methods.

Renato Tozzoli1, Nicola Bizzaro, Elio Tonutti, Marco Pradella, Fabio Manoni, Danilo Vilalta, Danila Bassetti, Anna Piazza, Paolo Rizzotti.   

Abstract

The use of highly sensitive immunometric methods in clinical laboratories to assay anti-thyroid antibodies has progressively expanded in recent years but it is not known whether the new techniques have improved the analytical variability connected with the preceding methodologies. The Italian Society of Laboratory Medicine Study Group on Autoimmune Diseases conducted a collaborative study with the biomedical industry to evaluate the degree of standardization of the new analytical procedures. Twelve companies agreed to participate in the study on the search for anti-thyroglobulin (anti-Tg) and anti-thyroperoxidase (anti-TPO) antibodies in nine sera from patients with autoimmune thyroiditis, and in six sera from patients with non-autoimmune thyroid disease; ten immunometric and three immunofluorescence methods were employed. Agreement of qualitative results was close to 90% for anti-Tg and 97% for anti-TPO, with no important differences between the methods; variability of the quantitative results, expressed as CV% of absolute (in lU/ml) and relative (in cut-off concentration multiples) values was 93.9% and 102.3%, respectively, for anti-Tg, and 75.5% and 62.9%, respectively, for anti-TPO. These findings show that despite the progressive improvement in the analytical techniques, the variability between methods for the assay of anti-Tg and anti-TPO is still unexpectedly high, and probably due to several factors such as uncertainty in defining the positive cutoff concentration, absence of adequate international reference preparations, modality of autoantigen purification, and analytical variability in the assay procedures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12211650     DOI: 10.1515/CCLM.2002.098

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  7 in total

1.  Accuracy of semiquantitative immunoenzymatic methods in quantitation of anti-topoisomerase I (Scl-70) antibodies.

Authors:  D Villalta; N Bizzaro; S Platzgummer; A Antico; M Tampoia; L Camogliano; D Bassetti; M Pradella; A Piazza; F Manoni; R Tozzoli; E Tonutti
Journal:  Clin Rheumatol       Date:  2004-12-10       Impact factor: 2.980

2.  The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid Cancer.

Authors:  Inhwa Lee; Hyeung Kyoo Kim; Euy Young Soh; Jeonghun Lee
Journal:  World J Surg       Date:  2020-05       Impact factor: 3.352

Review 3.  Diagnostic accuracy of immunoassays for the detection of antibodies to citrullinated proteins.

Authors:  Nicola Bizzaro; Marilina Tampoia
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

4.  Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival.

Authors:  Alessandra De Remigis; Tanja D de Gruijl; Jennifer N Uram; Schey-Cherng Tzou; Shintaro Iwama; Monica V Talor; Todd D Armstrong; Saskia J A M Santegoets; Susan F Slovin; Lei Zheng; Daniel A Laheru; Elizabeth M Jaffee; Winald R Gerritsen; Alfons J M van den Eertwegh; Dung T Le; Patrizio Caturegli
Journal:  Int J Cancer       Date:  2014-05-28       Impact factor: 7.396

5.  Establishment of the upper reference limit for thyroid peroxidase autoantibodies according to the guidelines proposed by the National Academy of Clinical Biochemistry: comparison of five different automated methods.

Authors:  Federica D'Aurizio; Paolo Metus; Annalisa Polizzi Anselmo; Danilo Villalta; Anna Ferrari; Roberto Castello; Graziella Giani; Elio Tonutti; Nicola Bizzaro; Renato Tozzoli
Journal:  Auto Immun Highlights       Date:  2015-08-15

6.  Definition of the upper reference limit for thyroglobulin antibodies according to the National Academy of Clinical Biochemistry guidelines: comparison of eleven different automated methods.

Authors:  F D'Aurizio; P Metus; A Ferrari; B Caruso; R Castello; D Villalta; A Steffan; K Gaspardo; F Pesente; N Bizzaro; E Tonutti; S Valverde; C Cosma; M Plebani; R Tozzoli
Journal:  Auto Immun Highlights       Date:  2017-06-19

Review 7.  Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper.

Authors:  Luca Giovanella; Penelope M Clark; Luca Chiovato; Leonidas Duntas; Rossella Elisei; Ulla Feldt-Rasmussen; Laurence Leenhardt; Markus Luster; Camilla Schalin-Jäntti; Matthias Schott; Ettore Seregni; Herald Rimmele; Jan Smit; Frederik A Verburg
Journal:  Eur J Endocrinol       Date:  2014-04-17       Impact factor: 6.664

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.